Stocks · News reference
TD Cowen analyst Robert Moskow maintains Simply Good Foods (NASDAQ:SMPL) with a Hold and lowers the price target from $13 to $11.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Following recent earnings reports, multiple financial institutions including UBS, Deutsche Bank, and Jefferies have adjusted their price targets and ratings for The Simply Good Foods Company.
Grabar Law Office has launched multiple shareholder investigations into four public companies for alleged securities fraud and breach of fiduciary duties. Erasca is accused of making misleading statements about its ERAS-0015 drug candidate and failing to disclose patent infringement risks from Revolution Medicines. Planet Fitness faces allegations of false marketing claims and concealing declining customer acquisition metrics. PROCEPT BioRobotics is investigated for undisclosed discount programs that artificially inflated sales figures and created excess inventory. The Simply Good Foods Company is accused of failing to disclose operational failures and margin erosion related to its OWYN acquisition.
Grabar Law Office has announced an investigation into potential breaches of fiduciary duty by officers and directors of The Simply Good Foods Company regarding alleged misleading statements.
The Simply Good Foods Company announced its financial results for the fourth quarter and full fiscal year 2026, alongside its outlook for fiscal year 2027.
Filed: 2026-10-27 AccNo: 0001702744-26-000028 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Simply Good Foods is expected to report a year-over-year decline in earnings and revenues for Q3 2026 (quarter ended August 2026). The company is projected to post EPS of $0.40 (down 13% YoY) and revenues of $326.87 million (down 11.4% YoY). With a positive Earnings ESP of +0.84% but a Zacks Rank of #4, the stock is not considered a compelling earnings-beat candidate, though the company has beaten consensus estimates in 3 of the last 4 quarters.